Leveraging genetic insights throughout the drug discovery pipeline
Robert M. Plenge, MD, PhD, senior vice president in research and early development, and head of the immunology, cardiovascular, fibrosis and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.